Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lipocine (LPCN) Long-Term Deferred Tax (2020 - 2023)

Lipocine's Long-Term Deferred Tax history spans 2 years, with the latest figure at $47.8 million for Q4 2023.

  • For Q4 2023, Long-Term Deferred Tax changed N/A year-over-year to $47.8 million; the TTM value through Dec 2023 reached $47.8 million, changed N/A, while the annual FY2023 figure was $47.8 million, N/A changed from the prior year.
  • Long-Term Deferred Tax reached $47.8 million in Q4 2023 per LPCN's latest filing, up from $36000.0 in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $47.8 million in Q4 2023 to a low of $36000.0 in Q4 2020.